Abstract:Background: Elevated levels of S-adenosylhomocysteine (SAH), the precursor of homocysteine, are positively associated with the risk of cardiovascular disease and with the development and progression of atherosclerosis. However, the role of SAH in endothelial dysfunction is unclear. Methods: Apolipoprotein E–deficient (apoE−/−) mice received dietary supplementation with the SAH hydrolase (SAHH) inhibitor adenosine dialdehyde or were intravenously injected with a retrovirus expressing SAHH shRNA. These 2 approaches, along with the heterozygous SAHH gene knockout (SAHH+/−) mouse model, were used to elevate plasma SAH levels and to examine the role of SAH in aortic endothelial dysfunction. The relationship between plasma SAH levels and endothelial dysfunction was also investigated in human patients with coronary artery disease and healthy control subjects. Results: Plasma SAH levels were increased in SAHH+/− mice and in apoE−/− mice after dietary administration of adenosine dialdehyde or intravenous injection with SAHH shRNA. SAHH+/− mice or apoE−/− mice with SAHH inhibition showed impaired endothelium-dependent vascular relaxation and decreased nitric oxide bioavailability after treatment with acetylcholine; this was completely abolished by the administration of the endothelial nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester. Furthermore, SAHH inhibition induced production of reactive oxygen species and p66shc expression in the mouse aorta and human aortic endothelial cells. Antioxidants and p66shc siRNA prevented SAHH inhibition–induced generation of reactive oxygen species and attenuated the impaired endothelial vasomotor responses in high-SAH mice. Moreover, inhibition of SAHH induced hypomethylation in the p66shc gene promoter and inhibited expression of DNA methyltransferase 1. Overexpression of DNA methyltransferase 1, induced by transduction of an adenovirus, was sufficient to abrogate SAHH inhibition–induced upregulation of p66shc expression. Finally, plasma SAH levels were inversely associated with flow-mediated dilation and hypomethylation of the p66shc gene promoter and positively associated with oxidative stress levels in patients with coronary artery disease and healthy control subjects. Conclusions: Our findings indicate that inhibition of SAHH results in elevated plasma SAH levels and induces endothelial dysfunction via epigenetic upregulation of the p66shc-mediated oxidative stress pathway. Our study provides novel molecular insight into mechanisms of SAH-associated endothelial injury that may contribute to the development of atherosclerosis. Clinical Trial Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT03345927.

Abstract 214: Sumo2 Regulates Oxidative Function Of Adaptor Protein P66shc

Abstract 14657: p66Shc Mediates SUMO2-Induced Endothelial Dysfunction and ROS Production

P66Shc Mediates SUMO2-induced Endothelial Dysfunction

Sirtuin1-regulated lysine acetylation of p66Shc governs diabetes-induced vascular oxidative stress and endothelial dysfunction

SUMO-Modification of Human Nrf2 at K110 and K533 Regulates Its Nucleocytoplasmic Localization, Stability and Transcriptional Activity

Dual Role of Endothelial Nitric Oxide Synthase in Oxidized LDL-Induced, p66Shc-Mediated Oxidative Stress in Cultured Human Endothelial Cells

Erk Phosphorylates P66shca On Ser36 And Subsequently Regulates P27(Kip1) Expression Via The Akt-Foxo3a Pathway: Implication Of P27(Kip1) In Cell Response To Oxidative Stress

The Protein S-nitrosylation of Splicing and Translational Machinery in Vascular Endothelial Cells is Susceptible to Oxidative Stress Induced by Oxidized Low-Density Lipoprotein.

p66Shc links alpha1-adrenergic receptors to a reactive oxygen species-dependent AKT-FOXO3A phosphorylation pathway in cardiomyocytes

p66Shc Protein—Oxidative Stress Sensor or Redox Enzyme: Its Potential Role in Mitochondrial Metabolism of Human Breast Cancer

p66Shc in Cardiovascular Pathology

Abstract 257: Oxidative Stress Induces Endothelial Dysfunction: Role of Ubiquitin-Proteasome System

Inhibition of S-Adenosylhomocysteine Hydrolase Induces Endothelial Dysfunction Via Epigenetic Regulation of P66shc-Mediated Oxidative Stress Pathway

SUMOylation Enhances the Activity of IDH2 under Oxidative Stress.

SUMO‐specific proteases: SENPs in oxidative stress‐related signaling and diseases

SUMOylation of the Ubiquitin Ligase Component KEAP1 at K39 Upregulates NRF2 and Its Target Function in Lung Cancer Cell Proliferation.

The Interplay Between SUMOylation and Phosphorylation of PKCδ Facilitates Oxidative Stress‐induced Apoptosis

USP15 Regulates P66shc Stability Associated with Drp1 Activation in Liver Ischemia/reperfusion

Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90.

SUMO2 and SUMO3 transcription is differentially regulated by oxidative stress in an Sp1-dependent manner.

Abstract Or110: Inflammation-induced endothelial cell activation and angiogenic sprouting are downmodulated by ubiquitin-specific peptidase 20